Proteomic analysis reveals that KAE modulates multiple oncogenic pathways, including inhibition of EGFR family members and downstream signaling, as well as pronounced suppression of targets associated with tumor invasion, metastasis, and survival, such as survivin and Snail. This evidence concerns the gene EGFR and neoplasm.